latamoxef (Q3827439)

Latamoxef (English)

17 November 2015

Latamoxef.svg
512 × 203; 14 KB

0 references

mass

520.101 dalton

1 reference

Latamoxef (English)

18 November 2016

C₂₀H₂₀N₆O₉S

1 reference

Latamoxef (English)

18 November 2016

CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O

1 reference

Latamoxef (English)

18 November 2016

CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O

1 reference

parenteral route of administration

Latamoxef (English)

18 November 2016

4 gram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=J01DD06

World Health Organisation international non-proprietary name

latamoxef (English)

1 reference

moxalactam (English)

medical condition treated

4 October 2016

bacterial infectious disease

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/VUF6C936Z3

2 November 2018

reference URL

http://www.mims.com/singapore/drug/info/latamoxef?mtype=generic

subject has role

antibiotic

1 reference

‎WHO Aware Classification

Medical Subject Headings

15 March 2018

2 references

watch

1 reference

2023 ‎AWaRe classification‎

different from

latamoxef disodium

0 references

Commons category

Latamoxef

0 references

Identifiers

InChI

InChI=1S/C20H20N6O9S/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32)/t12?,18-,20+/m1/s1

1 reference

Latamoxef (English)

18 November 2016

2 references

Latamoxef (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

64952-97-2

1 reference

latamoxef (English)

18 November 2016

1 reference

Latamoxef (English)

18 November 2016

2 references

Latamoxef (English)

18 November 2016

Reaxys registry number

4222777

1 reference

moxalactam (English)

4 October 2016

mapping relation type

2 references

MOXALACTAM (English)

18 November 2016

International Chemical Identifier

InChI

InChI=1S/C20H20N6O9S/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32)/t12?,18-,20+/m1/s1

1 reference

MOXALACTAM (English)

18 November 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

0 references

1 reference

latamoxef (English)

ECHA Substance Infocard ID

18 November 2016

100.059.334

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Latamoxef (English)

CAS no.: 64952-97-2 (English)

1 reference

Latamoxef (English)

17 November 2015

Moxalactam

1 reference

Medical Subject Headings

14 March 2018

0 references

0 references

0 references

1 reference

latamoxef (English)

18 November 2016

1 reference

Human Metabolome Database ID

HMDB0015574

2 references

based on heuristic

inferred from InChIKey

2 references

latamoxef (English)

18 November 2016

NDF-RT ID

N0000147933

1 reference

latamoxef (English)

18 November 2016

0 references

1 reference

1 reference

Immune Epitope Database and Analysis Resource

moxalactam (English)

4 October 2016

1 reference

1 March 2022

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI

C0026651

1 reference